OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
Conference call to be held on Thursday, May 2 at 4:30pm Eastern Time
BOTHELL, Wash. and VANCOUVER, Briti
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
The SGLT disease education campaign provides resources for healthcare professionals about the role of sodium glucose co-transporters in maintaining blood sugar balance
NeuroSigma Receives Health Canada Approval for Its Monarch eTNS System for the Treatment of Drug-Resistant Epilepsy and Major Depressive Disorder
Non-Invasive Neurostimulation System, Well-Received in Europe, Now Available in Canada for Adults and Children 9 years and older
LOS ANGE
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
-- Conference Call and Webcast Scheduled for Today at 5:15 p.m.
Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
NEW BRUNSWICK, N.J., May 2, 2013 /PRNewswire/ -- Janssen R&D Ireland (Janssen) and Johnson & Joh
Judge Nullifies Verdict in Diabetes Drug Case
DEERFIELD, Ill., May 1, 2013 -- Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Jack Cooper, et al. v. Takeda Pharmaceuticals America, Inc., et al., No. CGC-12-518535, the...
Four Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
Amgen's Breakaway from Cancer to Celebrate Cancer Survivors at Every Stage of the Eighth Annual Professional Cycling Race
THOUSAND OAKS,
ThromboGenics' JETREA® Available in Germany Public and Private Market
LEUVEN, Belgium, May 2, 2013 /PRNewswire/ --
The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies - Big or Small
How-to video, English and Spanish checklists available to aid advance planning
PHOENIX, May 1, 2013
Boehringer Ingelheim Pharmaceuticals, Inc. Announces Updates to Prescribing Information for Pradaxa® (dabigatran etexilate mesylate)
RIDGEFIELD, Conn., April 30, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Lilly Diabetes and Disney Publishing Worldwide Expand Collaboration
Custom Publications Will be Delivered to Families Affected by Type 1 Diabetes Throughout the World
INDIANAPOLIS,
OncoGenex Announces that the Borealis-2™ Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment
The OGX-427 ORCA™ Program Continues to Expand with Patient Enrollment Now Open for Second Phase 2 Trial of OGX-427 in Advanced Bladder Cancer
FDA approves Plan B One-Step emergency contraceptive without a prescription for women 15 years of age and older
FDA NEWS RELEASE: FDA approves Plan B One-Step emergency contraceptive without a prescription for women 15 years of age and older For Immediate Release: April 30, 2013 The U.S. Food and Drug...
Merck Wins FOSAMAX® (alendronate sodium) Federal Bellwether Trial Involving Atypical Femur Fracture Claims
Merck Wins FOSAMAX® (alendronate sodium) Federal Bellwether Trial Involving Atypical Femur Fracture Claims Monday, April 29, 2013 WHITEHOUSE STATION, N.J.--Merck, known as MSD outside the United...
Bayer to acquire Conceptus, Inc.
Adds Essure®, the only non-surgical permanent birth control method, to Bayer's contraception portfolio Leverkusen, Germany / Mountain View, Calif. (U.S.A.), April 29, 2013 – Bayer...
Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams
Employees will serve in communities in need, including Johannesburg, South Africa, where they will support Lilly's diabetes partnership with Project HOPE
DIFICID® (fidaxomicin) Tablets Approved in Australia
Specialised Therapeutics Australia to Launch DIFICID May 14, 2013
JERSEY CITY, N.J., April 26, 2013
Takeda Responds to Verdict in Diabetes Drug Case
DEERFIELD, Ill., April 26, 2013 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A.<
Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
- Discounts and rebates by pharmaceutical companies are a customary, appropriate and legal practice as recognized by the Government
EAST
POSITIVE CHMP OPINION FOR XTANDI (ENZALUTAMIDE) IN ADVANCED PROSTATE CANCER
Enzalutamide recommended for approval in the European Union (EU) for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after doce
THE LIBRARY: WEBINAR
The Basics of Biotech 101, 201 & 301
This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. This series provides an overview of the science and technology used to enable discovery and the processes scientists use to discover new therapeutics. Download now.
Latest Commentary
2013 looks great from top execs' perspective
How will pharma fare in 2013? It's complicated
Which FiercePharma news attracts the most readers online?
Giving thanks for turkey basters, and national holidays
10 Largest Settlements and Judgments
more
EVENTS
- CBI/IVT's Product Recalls Summit June 11-12, 2013 — Indianapolis, Indiana
- 4th Digital Pharma WestJune 24-27 — South San Francisco
- BioImmersion Three-Day CourseJuly 10-12 — Chicago, IL
